GSA Capital Partners LLP cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 62.9% in the ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ...

Barclays analyst Saket Kalia raised the firm’s price target on Autodesk (ADSK) to $355 from $310 and keeps an Overweight rating on the ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Amplitude ( AMPL -1.76%) is one such example. The software-as-a-service stock, which specializes in digital analytics and ...

Amazon wants to dominate the three core layers of artificial intelligence: infrastructure, large language models, and software.

Shares of Applied Digital surged in extended trading Thursday after Nvidia reported a stake in the company. Nvidia held a ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The stock currently trades at just under $18.00 a share and sports an approximate market capitalization of $2.95 billion.

the Australian Stock Exchange was told in a statement Monday. The 100 per cent takeover price was a premium of around 23 per cent over the closing price of Eumundi shares on October 29 ($1.26) when ...